Yu‐Hsuan Lan

602 citations
37 papers · 495 indexed · h-index 14
Topics
Drug Transport and Resistance Mechanisms (7 papers)Natural product bioactivities and synthesis (6 papers)Prostate Cancer Treatment and Research (6 papers)

In The Last Decade

Yu‐Hsuan Lan

35 papers receiving 491 citations

Peers

Yu‐Hsuan Lan
Comparison fields: 5 of 79
  • Molecular Biology 251
  • Pulmonary and Respiratory Medicine 126
  • Cancer Research 126
  • Oncology 94
  • Genetics 56
Replace Radka Václavíková with:
Radka Václavíková Czechia
Desen Liang China
Xuanfu Xu China
Sung‐Eun Hong South Korea
Yukai Xiang China
Michael Carducci United States
Ji Young Sul South Korea
Jacob Schwartzman United States
Ruisheng Yao United States
Yu‐Hsuan Lan relative to Radka Václavíková Czechia Radka Václavíková's profile →
Citations per field
00.5×1.5×1.9×
Radka Václavíková · 1×
Citations per year

Countries citing papers authored by Yu‐Hsuan Lan

Since Specialization
Citations

This map shows the geographic impact of Yu‐Hsuan Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Hsuan Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Hsuan Lan more than expected).

Fields of papers citing papers by Yu‐Hsuan Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Hsuan Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Hsuan Lan. The network helps show where Yu‐Hsuan Lan may publish in the future.

Co-authorship network of co-authors of Yu‐Hsuan Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Hsuan Lan. A scholar is included among the top collaborators of Yu‐Hsuan Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Hsuan Lan. Yu‐Hsuan Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4 10
5 3
6 10
7 4
8 3
9 13
10 1
11 22
12 9
13 4
14 19
15 22
16 11
17 15
18 64
19 8
20 23

About Yu‐Hsuan Lan

Yu‐Hsuan Lan is a scholar working on Biochemistry, Toxicology and Oncology, having authored 37 papers that have together received 495 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Natural product bioactivities and synthesis (6 papers) and Prostate Cancer Treatment and Research (6 papers). The work is most often cited by research in Cancer Research (126 citations), Pharmacology (43 citations) and Biochemistry (33 citations). Yu‐Hsuan Lan has collaborated with scholars based in Taiwan, Vietnam and United States. Frequent co-authors include Bo‐Ying Bao, Lumin Chen, Hong‐Zin Lee, Te‐Ling Lu, Ta-Yuan Chang, Chin‐Chuan Hung, Shu‐Pin Huang, Wen‐Chien Ting, Chi‐Jeng Hsieh and Tsong‐Long Hwang. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026